arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Viridian Therapeutics, Inc.DE

VRDN

$23.61 ▲ +1.10 (+4.89%) at close

13 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Viridian Therapeutics, Inc.DE faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 23359.9% ↗

Op. Margin None

ROIC -39.8% ↘

FCF / Share None

Trailing P/E —

Price / Book 3.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$70.85M

↑ +23359.9% —

Net Income Profit after all expenses

$-342.60M

↓ -26.9% —

Operating Margin Operating profit as % of sales

-394.5%

↑ +19.2% —

FCF / Share Free cash flow per share

$-4.14

↓ -40.2% —

Long-Term Debt Long-term obligations

$20.58M

↑ +1.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	23359.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+291899%)	-3.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-148%)	-82.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1128%)	-40.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-602%)	182.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2177%)	-76.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1056%)	-46.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-685%)	109.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1269%)	15.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+89%)	-39.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-588%)	-12.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-250%)	18.1% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+126%)	—
EPS Growth YoY (%)	—	—	-31.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	39.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	78.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-26.9% Weak ↑ Weak Improving Year-over-year change in net income	-13.6% Weak ↑ Weak Improving Year-over-year change in net income	-83.0% Weak ↓ Weak Declining Year-over-year change in net income	-63.5% Weak ↓ Weak Declining Year-over-year change in net income	28.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-164.4% Weak ↓ Weak Declining Year-over-year change in net income	-28.0% Weak ↑ Weak Improving Year-over-year change in net income	-23.4% Weak ↑ Weak Improving Year-over-year change in net income	-53.5% Weak ↑ Weak Improving Year-over-year change in net income	-52.5% Weak ↑ Weak Improving Year-over-year change in net income	-43.6% Weak Weak Year-over-year change in net income	-265.3% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	—	—	-40.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	36.0% Excellent Excellent Year-over-year change in free cash flow	45.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	241.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-53.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-33.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-26.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-29.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-36.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.7% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	13.7% Good ↑ Good Improving Compound annual revenue growth over 3 years	-14.9% Weak Weak Compound annual revenue growth over 3 years	-14.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	132.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-41.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-48.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-15.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-3.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-28.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-7.2% Weak Weak Compound annual revenue growth over 5 years	8.8% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	-394.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2730%)	—	-488.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3357%)	-196.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1407%)	-105.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-806%)	-3.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-124%)
Profit Margin (%) (%)	-483.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4130%)	—	—	—	—	—	—	-390.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3350%)	—	-496.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4240%)	-198.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1754%)	-121.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1114%)	-39.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-428%)
FCF Margin (%) (%)	-390.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-325.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-431.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-123.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-38.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-21.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	-39.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-43.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-26.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-141.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	21.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-84.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-90.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	0.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-40.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-40.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-51.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-30.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-84.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-138.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-86.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-84.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.4% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	-47.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-416%)	-40.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	-53.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-459%)	-32.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-42.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-382%)	-92.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-715%)	-265.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1872%)	-63.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-525%)	-68.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-559%)	27.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	-108.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-825%)	-131.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-978%)	9.0% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-40%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Debt to Equity (x)	—	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	—	—	—	—	—
Interest Coverage (x)	-169.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-164.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-137.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-268.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-26576.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-217.28x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-50.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-69.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-52.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-79.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	-0.10x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	—	$20.58M	$20.20M	$4.64M	$0.00	—	$7.67M	$-22.61M	$-47.44M	$-22.10M	$-10.83M	$-5.12M	—
Debt / EBITDA (x)	—	-0.07x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	—	—	$0.01	$0.06	$0.25	$0.30	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	—	$-5.31	$-4.05	$-6.66	$-31.13	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	$-4.14	$-2.95	$-4.61	$-8.38	—	—	—	—	—	—	—
Book Value per Share (USD)	$7.09	$8.29	$8.19	$9.56	$7.85	$28.37	$0.45	$1.66	$1.71	$-74.27	$0.98	$1.58	—
Tangible Book Value per Share (USD)	$7.09	$8.29	$8.19	$9.56	$7.85	$28.37	$0.45	$1.66	$1.71	$-74.27	$0.98	$1.58	—
Basic Weighted Avg Shares (shares)	—	—	44.76M	32.09M	11.92M	3.56M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$823.54M	$690.59M	$459.84M	$397.82M	$186.53M	$118.94M	$19.56M	$58.64M	$47.97M	$16.99M	$9.27M	$4.80M	$-25.25M
LT Debt (USD)	—	$20.58M	$20.20M	$4.64M	$0.00	—	$7.67M	$10.00M	—	—	—	—	—
Total Equity (USD)	$722.17M	$671.64M	$442.02M	$395.06M	$187.72M	$120.04M	$15.75M	$51.34M	$38.51M	$-61.92M	$10.41M	$5.99M	$-23.89M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$70.85M	$302.00K	$314.00K	$1.77M	$2.96M	$1.05M	$4.46M	$8.39M	$4.00M	$3.48M	$5.71M	$6.48M	$5.49M
Depreciation Expense (USD)	$460.00K	$540.00K	$522.00K	$255.00K	$120.00K	$239.00K	$288.00K	$281.00K	$308.00K	$341.00K	$184.00K	$144.00K	$148.00K
Net Income, GAAP (USD)	$-342.60M	$-269.95M	$-237.73M	$-129.87M	$-79.41M	$-110.72M	$-41.87M	$-32.70M	$-26.51M	$-17.27M	$-11.33M	$-7.89M	$-2.16M
Operating Cash Flow (USD)	$-276.39M	$-232.32M	$-184.17M	$-93.84M	$-54.58M	$-29.78M	$-36.06M	$-26.84M	$-28.17M	$-14.76M	$-6.90M	$-2.21M	$-1.17M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 53 quarters

Viridian Therapeutics, Inc.DE

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VRDN with peers